Carboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic drug delivery

被引:83
作者
Kaur, Harmanmeet [1 ]
Ahuja, Munish [2 ]
Kumar, Sandeep [1 ]
Dilbaghi, Neeraj [1 ]
机构
[1] Guru Jambheshwar Univ Sci & Technol, Dept Bio & Nano Technol, Nanomat Synth & Characterizat Lab, Hisar 125001, Haryana, India
[2] Guru Jambheshwar Univ Sci & Technol, Dept Pharmaceut Sci, Drug Delivery Res Lab, Hisar 125001, Haryana, India
关键词
Carboxymethyl tamarind kernel powder; Tropicamide; Ionotropic gelation; Nanoparticles; Corneal permeation; CHORIOALLANTOIC MEMBRANE; PHARMACOKINETICS; SAFETY;
D O I
10.1016/j.ijbiomac.2011.11.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Tropicamide-loaded carboxymethyl tamarind kernel polysaccharide (CMTKP) nanoparticles were prepared and evaluated for ocular delivery. Preparation of ionotropically gelled CMTKP nanoparticles was optimized employing three-levels, two-factor central composite design. Concentration of polymer and crosslinker had significant synergistic effect on particle size and % encapsulation efficiency. The optimal calculated parameters were concentrations of CMTKP 0.10% (w/v) and calcium chloride 0.11% (w/v). The optimized tropicamide-loaded CMTKP formulation showed ex vivo corneal permeation of tropicamide across isolated goat cornea comparable to its aqueous solution. Further, the mucoadhesive and non-irritant nature of CMTKP nanoparticles indicate their suitability as ocular delivery system. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:833 / 839
页数:7
相关论文
共 38 条
[1]
Nanomedicines for ocular NSAIDs: safety on drug delivery [J].
Araujo, Joana ;
Gonzalez, Elisabet ;
Egea, Maria Antonia ;
Garcia, Marisa Luisa ;
Souto, Eliana B. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2009, 5 (04) :394-401
[2]
Drug delivery to target the posterior segment of the eye [J].
Behar-Cohen, F .
M S-MEDECINE SCIENCES, 2004, 20 (6-7) :701-706
[3]
Blessel K.W., 1974, ANAL PROFILES DRUG S, P565
[4]
Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs [J].
Bu, Hai-Zhi ;
Gukasyan, Hovhannes J. ;
Goulet, Lance ;
Lou, Xiao-Jing ;
Xiang, Cathie ;
Koudriakova, Tatiana .
CURRENT DRUG METABOLISM, 2007, 8 (02) :91-107
[5]
Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers [J].
Calvo, P ;
VilaJato, JL ;
Alonso, MJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (05) :530-536
[6]
Cappello B., 2001, INT J PHARMACEUT, V7, P5
[7]
Ophthalmic vehicles containing polymer-solubilized tropicamide: "In vitro/in vivo" evaluation [J].
Carmignani, C ;
Rossi, S ;
Saettone, MF ;
Burgalassi, S .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (01) :101-105
[8]
Poly(2-hydroxyethyl methacrylate)-quercetin Conjugate as Biomaterial in Ophthalmology: An "ab initio" Study [J].
Curcio, Manuela ;
Cirillo, Giuseppe ;
Parisi, Ortensia Ilaria ;
Iemma, Francesca ;
Spizzirri, Umile Gianfranco ;
Altimari, Ilaria ;
Picci, Nevio ;
Puoci, Francesco .
JOURNAL OF FUNCTIONAL BIOMATERIALS, 2011, 2 (01) :1-17
[9]
Dey Surajit, 2005, Expert Opin Drug Deliv, V2, P201, DOI 10.1517/17425247.2.2.201
[10]
Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods [J].
Dhawan, S ;
Singla, AK ;
Sinha, VR .
AAPS PHARMSCITECH, 2004, 5 (04)